APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

End Stage Renal Disease

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global End Stage Renal Disease Industry Growth and Trends Forecast to 2032

Report ID 173988160128 December 2025112 pages

Choose your research edition.

Industry ResearchEnd Stage Renal Disease Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal End Stage Renal Disease Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal End Stage Renal Disease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal End Stage Renal Disease Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal End Stage Renal Disease Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

According to APO Research, the global End Stage Renal Disease market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for End Stage Renal Disease is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for End Stage Renal Disease is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for End Stage Renal Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the End Stage Renal Disease market include Newsol, Baxter, Guangdong Biolight, B. Braun, DaVita, Fresenius, Jafron Biomedical, Medtronic and Mayo Clinic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global End Stage Renal Disease market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The End Stage Renal Disease market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global End Stage Renal Disease market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to End Stage Renal Disease.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global End Stage Renal Disease market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

End Stage Renal Disease Market by Company

Newsol

Baxter

Guangdong Biolight

B. Braun

DaVita

Fresenius

Jafron Biomedical

Medtronic

Mayo Clinic

Nipro

Nikkiso

Sanxin Medtec

SWS Hemodialysis Care

Tianyi Medical

WEGO

Asahi Kasei

End Stage Renal Disease Segment by Type

Hemodialysis

Kidney Transplantation

Peritoneal Dialysis

End Stage Renal Disease Segment by Application

At Homes

Kidney Dialysis Centers

Hospitals

Others

End Stage Renal Disease Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global End Stage Renal Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of End Stage Renal Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of End Stage Renal Disease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of End Stage Renal Disease companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global End Stage Renal Disease Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global End Stage Renal Disease Market Size by Region (2021-2026) & (US$ Million) Table 3. Global End Stage Renal Disease Market Share by Region (2021-2026) Table 4. Global End Stage Renal Disease Market Size by Region (2027-2032) & (US$ Million) Table 5. Global End Stage Renal Disease Market Share by Region (2027-2032) Table 6. Global End Stage Renal Disease Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global End Stage Renal Disease Market Size by Type (2021-2026) & (US$ Million) Table 8. Global End Stage Renal Disease Market Size Share by Type (2021-2026) Table 9. Global End Stage Renal Disease Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global End Stage Renal Disease Market Size Share Forecasted by Type (2027-2032) Table 11. North America End Stage Renal Disease Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America End Stage Renal Disease Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe End Stage Renal Disease Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe End Stage Renal Disease Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific End Stage Renal Disease Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific End Stage Renal Disease Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America End Stage Renal Disease Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America End Stage Renal Disease Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa End Stage Renal Disease Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa End Stage Renal Disease Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global End Stage Renal Disease Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global End Stage Renal Disease Market Size by Application (2021-2026) & (US$ Million) Table 23. Global End Stage Renal Disease Market Size Share by Application (2021-2026) Table 24. Global End Stage Renal Disease Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global End Stage Renal Disease Market Size Share Forecasted by Application (2027-2032) Table 26. North America End Stage Renal Disease Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America End Stage Renal Disease Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe End Stage Renal Disease Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe End Stage Renal Disease Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific End Stage Renal Disease Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific End Stage Renal Disease Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America End Stage Renal Disease Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America End Stage Renal Disease Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa End Stage Renal Disease Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa End Stage Renal Disease Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. End Stage Renal Disease Industry Trends Table 37. End Stage Renal Disease Industry Drivers Table 38. End Stage Renal Disease Industry Opportunities and Challenges Table 39. End Stage Renal Disease Industry Restraints Table 40. Global End Stage Renal Disease Revenue by Company (US$ Million) & (2021-2026) Table 41. Global End Stage Renal Disease Revenue Market Share by Company (2021-2026) Table 42. Global End Stage Renal Disease Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global End Stage Renal Disease Key Company Headquarters & Area Served Table 44. Global End Stage Renal Disease Company, Product Type & Application Table 45. Global End Stage Renal Disease Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global End Stage Renal Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Newsol Company Information Table 49. Newsol Business Overview Table 50. Newsol End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Newsol End Stage Renal Disease Product Portfolio Table 52. Newsol Recent Development Table 53. Baxter Company Information Table 54. Baxter Business Overview Table 55. Baxter End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Baxter End Stage Renal Disease Product Portfolio Table 57. Baxter Recent Development Table 58. Guangdong Biolight Company Information Table 59. Guangdong Biolight Business Overview Table 60. Guangdong Biolight End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Guangdong Biolight End Stage Renal Disease Product Portfolio Table 62. Guangdong Biolight Recent Development Table 63. B. Braun Company Information Table 64. B. Braun Business Overview Table 65. B. Braun End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. B. Braun End Stage Renal Disease Product Portfolio Table 67. B. Braun Recent Development Table 68. DaVita Company Information Table 69. DaVita Business Overview Table 70. DaVita End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. DaVita End Stage Renal Disease Product Portfolio Table 72. DaVita Recent Development Table 73. Fresenius Company Information Table 74. Fresenius Business Overview Table 75. Fresenius End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Fresenius End Stage Renal Disease Product Portfolio Table 77. Fresenius Recent Development Table 78. Jafron Biomedical Company Information Table 79. Jafron Biomedical Business Overview Table 80. Jafron Biomedical End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Jafron Biomedical End Stage Renal Disease Product Portfolio Table 82. Jafron Biomedical Recent Development Table 83. Medtronic Company Information Table 84. Medtronic Business Overview Table 85. Medtronic End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Medtronic End Stage Renal Disease Product Portfolio Table 87. Medtronic Recent Development Table 88. Mayo Clinic Company Information Table 89. Mayo Clinic Business Overview Table 90. Mayo Clinic End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Mayo Clinic End Stage Renal Disease Product Portfolio Table 92. Mayo Clinic Recent Development Table 93. Nipro Company Information Table 94. Nipro Business Overview Table 95. Nipro End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Nipro End Stage Renal Disease Product Portfolio Table 97. Nipro Recent Development Table 98. Nikkiso Company Information Table 99. Nikkiso Business Overview Table 100. Nikkiso End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Nikkiso End Stage Renal Disease Product Portfolio Table 102. Nikkiso Recent Development Table 103. Sanxin Medtec Company Information Table 104. Sanxin Medtec Business Overview Table 105. Sanxin Medtec End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sanxin Medtec End Stage Renal Disease Product Portfolio Table 107. Sanxin Medtec Recent Development Table 108. SWS Hemodialysis Care Company Information Table 109. SWS Hemodialysis Care Business Overview Table 110. SWS Hemodialysis Care End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. SWS Hemodialysis Care End Stage Renal Disease Product Portfolio Table 112. SWS Hemodialysis Care Recent Development Table 113. Tianyi Medical Company Information Table 114. Tianyi Medical Business Overview Table 115. Tianyi Medical End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Tianyi Medical End Stage Renal Disease Product Portfolio Table 117. Tianyi Medical Recent Development Table 118. WEGO Company Information Table 119. WEGO Business Overview Table 120. WEGO End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. WEGO End Stage Renal Disease Product Portfolio Table 122. WEGO Recent Development Table 123. Asahi Kasei Company Information Table 124. Asahi Kasei Business Overview Table 125. Asahi Kasei End Stage Renal Disease Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Asahi Kasei End Stage Renal Disease Product Portfolio Table 127. Asahi Kasei Recent Development Table 128. North America End Stage Renal Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America End Stage Renal Disease Market Size by Country (2021-2026) & (US$ Million) Table 130. North America End Stage Renal Disease Market Share by Country (2021-2026) Table 131. North America End Stage Renal Disease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America End Stage Renal Disease Market Share Forecast by Country (2027-2032) Table 133. Europe End Stage Renal Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe End Stage Renal Disease Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe End Stage Renal Disease Market Share by Country (2021-2026) Table 136. Europe End Stage Renal Disease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe End Stage Renal Disease Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific End Stage Renal Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific End Stage Renal Disease Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific End Stage Renal Disease Market Share by Country (2021-2026) Table 141. Asia-Pacific End Stage Renal Disease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific End Stage Renal Disease Market Share Forecast by Country (2027-2032) Table 143. Latin America End Stage Renal Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America End Stage Renal Disease Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America End Stage Renal Disease Market Share by Country (2021-2026) Table 146. Latin America End Stage Renal Disease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America End Stage Renal Disease Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa End Stage Renal Disease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa End Stage Renal Disease Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa End Stage Renal Disease Market Share by Country (2021-2026) Table 151. Middle East & Africa End Stage Renal Disease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa End Stage Renal Disease Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. End Stage Renal Disease Product Image Figure 3. Global End Stage Renal Disease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global End Stage Renal Disease Market Size (2021-2032) & (US$ Million) Figure 5. Global End Stage Renal Disease Market Share by Region: 2025 VS 2032 Figure 6. Global End Stage Renal Disease Market Share by Region (2021-2032) Figure 7. North America End Stage Renal Disease Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe End Stage Renal Disease Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific End Stage Renal Disease Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America End Stage Renal Disease Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa End Stage Renal Disease Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Hemodialysis Image Figure 13. Global Hemodialysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Kidney Transplantation Image Figure 15. Global Kidney Transplantation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Peritoneal Dialysis Image Figure 17. Global Peritoneal Dialysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global End Stage Renal Disease Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global End Stage Renal Disease Market Share by Type 2025 VS 2032 Figure 20. North America End Stage Renal Disease Market Size Share by Type (2021-2032) Figure 21. Europe End Stage Renal Disease Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific End Stage Renal Disease Market Size Share by Type (2021-2032) Figure 23. Latin America End Stage Renal Disease Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa End Stage Renal Disease Market Size Share by Type (2021-2032) Figure 25. At Homes Image Figure 26. Global At Homes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Kidney Dialysis Centers Image Figure 28. Global Kidney Dialysis Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Hospitals Image Figure 30. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global End Stage Renal Disease Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global End Stage Renal Disease Market Share by Application 2025 VS 2032 Figure 35. North America End Stage Renal Disease Market Size Share by Application (2021-2032) Figure 36. Europe End Stage Renal Disease Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific End Stage Renal Disease Market Size Share by Application (2021-2032) Figure 38. Latin America End Stage Renal Disease Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa End Stage Renal Disease Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 End Stage Renal Disease Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America End Stage Renal Disease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America End Stage Renal Disease Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America End Stage Renal Disease Market Share by Country (2021-2032) Figure 45. Europe End Stage Renal Disease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe End Stage Renal Disease Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe End Stage Renal Disease Market Share by Country (2021-2032) Figure 48. Asia-Pacific End Stage Renal Disease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific End Stage Renal Disease Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific End Stage Renal Disease Market Share by Country (2021-2032) Figure 51. Latin America End Stage Renal Disease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America End Stage Renal Disease Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America End Stage Renal Disease Market Share by Country (2021-2032) Figure 54. Middle East & Africa End Stage Renal Disease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa End Stage Renal Disease Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa End Stage Renal Disease Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Hemodialysis
  • Kidney Transplantation
  • Peritoneal Dialysis
Applications
  • At Homes
  • Kidney Dialysis Centers
  • Hospitals
  • Others
Companies covered
  • Newsol
  • Baxter
  • Guangdong Biolight
  • B. Braun
  • DaVita
  • Fresenius
  • Jafron Biomedical
  • Medtronic
  • Mayo Clinic
  • Nipro
  • Nikkiso
  • Sanxin Medtec
  • SWS Hemodialysis Care
  • Tianyi Medical
  • WEGO
  • Asahi Kasei

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global End Stage Renal Disease Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global End Stage Renal Disease Market Size by Region (2021-2032)
  5. 1.4.1 Global End Stage Renal Disease Market Size by Region (2021-2026)
  6. 1.4.2 Global End Stage Renal Disease Market Size by Region (2027-2032)
  7. 1.5 Key Regions End Stage Renal Disease Market Size (2021-2032)
  8. 1.5.1 North America End Stage Renal Disease Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe End Stage Renal Disease Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific End Stage Renal Disease Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America End Stage Renal Disease Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa End Stage Renal Disease Market Size Growth Rate (2021-2032)
2 End Stage Renal Disease Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Hemodialysis
  3. 2.1.2 Kidney Transplantation
  4. 2.1.3 Peritoneal Dialysis
  5. 2.2 Global End Stage Renal Disease Market Size by Type
  6. 2.2.1 Global End Stage Renal Disease Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global End Stage Renal Disease Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global End Stage Renal Disease Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global End Stage Renal Disease Market Size by Regions
  10. 2.3.1 North America End Stage Renal Disease Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe End Stage Renal Disease Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific End Stage Renal Disease Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America End Stage Renal Disease Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa End Stage Renal Disease Market Size Breakdown by Type (2021-2026)
3 End Stage Renal Disease Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 At Homes
  3. 3.1.2 Kidney Dialysis Centers
  4. 3.1.3 Hospitals
  5. 3.1.4 Others
  6. 3.2 Global End Stage Renal Disease Market Size by Application
  7. 3.2.1 Global End Stage Renal Disease Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global End Stage Renal Disease Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global End Stage Renal Disease Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global End Stage Renal Disease Market Size by Regions
  11. 3.3.1 North America End Stage Renal Disease Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe End Stage Renal Disease Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific End Stage Renal Disease Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America End Stage Renal Disease Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa End Stage Renal Disease Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 End Stage Renal Disease Industry Trends
  2. 4.2 End Stage Renal Disease Industry Drivers
  3. 4.3 End Stage Renal Disease Industry Opportunities and Challenges
  4. 4.4 End Stage Renal Disease Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by End Stage Renal Disease Revenue (2021-2026)
  2. 5.2 Global End Stage Renal Disease Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global End Stage Renal Disease Key Company Headquarters & Area Served
  4. 5.4 Global End Stage Renal Disease Company, Product Type & Application
  5. 5.5 Global End Stage Renal Disease Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global End Stage Renal Disease Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 End Stage Renal Disease Players Market Share by Revenue in 2025
  9. 5.6.3 2025 End Stage Renal Disease Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Newsol
  2. 6.1.1 Newsol Company Information
  3. 6.1.2 Newsol Business Overview
  4. 6.1.3 Newsol End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Newsol End Stage Renal Disease Product Portfolio
  6. 6.1.5 Newsol Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Baxter End Stage Renal Disease Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 Guangdong Biolight
  14. 6.3.1 Guangdong Biolight Company Information
  15. 6.3.2 Guangdong Biolight Business Overview
  16. 6.3.3 Guangdong Biolight End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Guangdong Biolight End Stage Renal Disease Product Portfolio
  18. 6.3.5 Guangdong Biolight Recent Developments
  19. 6.4 B. Braun
  20. 6.4.1 B. Braun Company Information
  21. 6.4.2 B. Braun Business Overview
  22. 6.4.3 B. Braun End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 B. Braun End Stage Renal Disease Product Portfolio
  24. 6.4.5 B. Braun Recent Developments
  25. 6.5 DaVita
  26. 6.5.1 DaVita Company Information
  27. 6.5.2 DaVita Business Overview
  28. 6.5.3 DaVita End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 DaVita End Stage Renal Disease Product Portfolio
  30. 6.5.5 DaVita Recent Developments
  31. 6.6 Fresenius
  32. 6.6.1 Fresenius Company Information
  33. 6.6.2 Fresenius Business Overview
  34. 6.6.3 Fresenius End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius End Stage Renal Disease Product Portfolio
  36. 6.6.5 Fresenius Recent Developments
  37. 6.7 Jafron Biomedical
  38. 6.7.1 Jafron Biomedical Company Information
  39. 6.7.2 Jafron Biomedical Business Overview
  40. 6.7.3 Jafron Biomedical End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Jafron Biomedical End Stage Renal Disease Product Portfolio
  42. 6.7.5 Jafron Biomedical Recent Developments
  43. 6.8 Medtronic
  44. 6.8.1 Medtronic Company Information
  45. 6.8.2 Medtronic Business Overview
  46. 6.8.3 Medtronic End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Medtronic End Stage Renal Disease Product Portfolio
  48. 6.8.5 Medtronic Recent Developments
  49. 6.9 Mayo Clinic
  50. 6.9.1 Mayo Clinic Company Information
  51. 6.9.2 Mayo Clinic Business Overview
  52. 6.9.3 Mayo Clinic End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Mayo Clinic End Stage Renal Disease Product Portfolio
  54. 6.9.5 Mayo Clinic Recent Developments
  55. 6.10 Nipro
  56. 6.10.1 Nipro Company Information
  57. 6.10.2 Nipro Business Overview
  58. 6.10.3 Nipro End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Nipro End Stage Renal Disease Product Portfolio
  60. 6.10.5 Nipro Recent Developments
  61. 6.11 Nikkiso
  62. 6.11.1 Nikkiso Company Information
  63. 6.11.2 Nikkiso Business Overview
  64. 6.11.3 Nikkiso End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Nikkiso End Stage Renal Disease Product Portfolio
  66. 6.11.5 Nikkiso Recent Developments
  67. 6.12 Sanxin Medtec
  68. 6.12.1 Sanxin Medtec Company Information
  69. 6.12.2 Sanxin Medtec Business Overview
  70. 6.12.3 Sanxin Medtec End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sanxin Medtec End Stage Renal Disease Product Portfolio
  72. 6.12.5 Sanxin Medtec Recent Developments
  73. 6.13 SWS Hemodialysis Care
  74. 6.13.1 SWS Hemodialysis Care Company Information
  75. 6.13.2 SWS Hemodialysis Care Business Overview
  76. 6.13.3 SWS Hemodialysis Care End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 SWS Hemodialysis Care End Stage Renal Disease Product Portfolio
  78. 6.13.5 SWS Hemodialysis Care Recent Developments
  79. 6.14 Tianyi Medical
  80. 6.14.1 Tianyi Medical Company Information
  81. 6.14.2 Tianyi Medical Business Overview
  82. 6.14.3 Tianyi Medical End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Tianyi Medical End Stage Renal Disease Product Portfolio
  84. 6.14.5 Tianyi Medical Recent Developments
  85. 6.15 WEGO
  86. 6.15.1 WEGO Company Information
  87. 6.15.2 WEGO Business Overview
  88. 6.15.3 WEGO End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 WEGO End Stage Renal Disease Product Portfolio
  90. 6.15.5 WEGO Recent Developments
  91. 6.16 Asahi Kasei
  92. 6.16.1 Asahi Kasei Company Information
  93. 6.16.2 Asahi Kasei Business Overview
  94. 6.16.3 Asahi Kasei End Stage Renal Disease Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Asahi Kasei End Stage Renal Disease Product Portfolio
  96. 6.16.5 Asahi Kasei Recent Developments
7 North America
  1. 7.1 North America End Stage Renal Disease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America End Stage Renal Disease Market Size by Country (2021-2026)
  3. 7.3 North America End Stage Renal Disease Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe End Stage Renal Disease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe End Stage Renal Disease Market Size by Country (2021-2026)
  3. 8.3 Europe End Stage Renal Disease Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific End Stage Renal Disease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific End Stage Renal Disease Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific End Stage Renal Disease Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America End Stage Renal Disease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America End Stage Renal Disease Market Size by Country (2021-2026)
  3. 10.3 South America End Stage Renal Disease Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa End Stage Renal Disease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa End Stage Renal Disease Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa End Stage Renal Disease Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst